{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T09:16:40Z","timestamp":1773047800885,"version":"3.50.1"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,1,26]],"date-time":"2024-01-26T00:00:00Z","timestamp":1706227200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontierspartnerships.org"],"crossmark-restriction":true},"short-container-title":["Transpl Int"],"abstract":"<jats:p>Restrictive allograft syndrome (RAS) is an aggressive variant of CLAD characterized by progressive restrictive ventilatory decline and persistent pleuro-parenchymal changes that can be seen on chest CT. We identified four lung transplant recipients with a progressive restrictive ventilatory defect due to lymphocyte-predominant exudative pleural effusions, but no pleuro-parenchymal abnormalities typical of RAS. Using molecular analysis, we also found increased levels of previously described immune markers of RAS, including NFkB, 20S proteasome, lipocalin, TNF\u03b1, and TGF\u03b2, within the circulating small extracellular vesicles of the remaining living lung transplant recipient. Despite the absence of lung parenchymal changes, these patients had a poor prognosis with rapid deterioration in allograft function and no response to pleural-based interventions such as thoracentesis, decortication, and pleurodesis. We hypothesize that these cases represent a distinct CLAD phenotype characterized by progressive restriction due to pleural inflammation, lymphocyte-predominant pleural effusion, resultant compressive atelectasis, and eventual respiratory failure in the absence of lung parenchymal involvement.<\/jats:p>","DOI":"10.3389\/ti.2024.12395","type":"journal-article","created":{"date-parts":[[2024,1,26]],"date-time":"2024-01-26T04:11:33Z","timestamp":1706242293000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Late-Onset Exudative Pleural Effusions Without Concomitant Airway Obstruction or Lung Parenchymal Abnormalities: A Novel Presentation of Chronic Lung Allograft Dysfunction"],"prefix":"10.3389","volume":"37","author":[{"given":"Devika","family":"Sindu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandhya","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhuvin","family":"Buddhdev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kendra","family":"McAnally","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hesham","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajat","family":"Walia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thalachallour","family":"Mohanakumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofya","family":"Tokman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,1,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1183\/09031936.00107514","article-title":"An International ISHLT\/ATS\/ERS Clinical Practice Guideline: Diagnosis and Management of Bronchiolitis Obliterans Syndrome","volume":"44","author":"Meyer","year":"2014","journal-title":"Eur Respir J"},{"key":"B2","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.healun.2019.03.008","article-title":"Chronic Lung Allograft Dysfunction: Definition and Update of Restrictive Allograft Syndrome\u2015A Consensus Report From the Pulmonary Council of the ISHLT","volume":"38","author":"Glanville","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"B3","doi-asserted-by":"publisher","first-page":"418","DOI":"10.21037\/atm.2020.02.159","article-title":"Bronchiolitis Obliterans Syndrome and Restrictive Allograft Syndrome After Lung Transplantation: Why Are There Two Distinct Forms of Chronic Lung Allograft Dysfunction?","volume":"8","author":"Sato","year":"2020","journal-title":"Ann Translational Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.healun.2011.01.712","article-title":"Restrictive Allograft Syndrome (RAS): A Novel Form of Chronic Lung Allograft Dysfunction","volume":"30","author":"Sato","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"B5","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.healun.2019.03.009","article-title":"Chronic Lung Allograft Dysfunction: Definition, Diagnostic Criteria, and Approaches to Treatment\u2015A Consensus Report From the Pulmonary Council of the ISHLT","volume":"38","author":"Verleden","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"B6","doi-asserted-by":"publisher","first-page":"S70","DOI":"10.1016\/j.healun.2014.01.223","article-title":"Phenotypes of Chronic Lung Allograft Dysfunction (CLAD): A Multilevel Diagnostic Approach","volume":"33","author":"Koutsokera","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"B7","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.healun.2020.04.012","article-title":"Risk Assessment of Chronic Lung Allograft Dysfunction Phenotypes: Validation and Proposed Refinement of the 2019 International Society for Heart and Lung Transplantation Classification System","volume":"39","author":"Levy","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"B8","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.healun.2012.09.026","article-title":"Progression Pattern of Restrictive Allograft Syndrome After Lung Transplantation","volume":"32","author":"Sato","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"B9","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1183\/09031936.00134307","article-title":"A Dichotomy in Bronchiolitis Obliterans Syndrome After Lung Transplantation Revealed by Azithromycin Therapy","volume":"32","author":"Vanaudenaerde","year":"2008","journal-title":"Eur Respir J"},{"key":"B10","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1016\/j.healun.2019.01.059","article-title":"Identification and Characterization of Patients With a Mixed Phenotype of CLAD","volume":"38","author":"Verleden","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"B11","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.healun.2021.09.001","article-title":"Restrictive Allograft Syndrome vs Bronchiolitis Obliterans Syndrome: Immunological and Molecular Characterization of Circulating Exosomes","volume":"41","author":"Bansal","year":"2022","journal-title":"J Heart Lung Transplant"},{"key":"B12","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/S1010-7940(03)00020-4","article-title":"Late Postoperative Pleural Effusion Following Lung Transplantation: Characteristics and Clinical Implications","volume":"23","author":"Shitrit","year":"2003","journal-title":"Eur J Cardio-Thoracic Surg"},{"key":"B13","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.athoracsur.2020.06.052","article-title":"Natural History of Pleural Complications After Lung Transplantation","volume":"111","author":"Tang","year":"2021","journal-title":"Ann Thorac Surg"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e14267","DOI":"10.1111\/ctr.14267","article-title":"Characteristics and Clinical Implications of Pleural Effusions After Lung Transplantation: A Retrospective Analysis of 195 Thoracocenteses in 113 Patients","volume":"35","author":"Joean","year":"2021","journal-title":"Clin Transplant"},{"key":"B15","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ejrad.2017.06.008","article-title":"CT at Onset of Chronic Lung Allograft Dysfunction in Lung Transplant Patients Predicts Development of the Restrictive Phenotype and Survival","volume":"94","author":"Dettmer","year":"2017","journal-title":"Eur J Radiol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.2214\/ajr.181.6.1811539","article-title":"Fibrosis of the Upper Lobes: A Newly Identified Late-Onset Complication After Lung Transplantation?","volume":"181","author":"Konen","year":"2003","journal-title":"Am J Roentgenology"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1016\/j.healun.2020.07.001","article-title":"Circulating Exosomes With Lung Self-Antigens as a Biomarker for Chronic Lung Allograft Dysfunction: A Retrospective Analysis","volume":"39","author":"Sharma","year":"2020","journal-title":"J Heart Lung Transplant : official Publ Int Soc Heart Transplant"},{"key":"B18","doi-asserted-by":"publisher","first-page":"6799","DOI":"10.1038\/s41598-021-85949-1","article-title":"Potential Novel Biomarkers for Chronic Lung Allograft Dysfunction and Azithromycin Responsive Allograft Dysfunction","volume":"11","author":"Veraar","year":"2021","journal-title":"Scientific Rep"},{"key":"B19","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.healun.2019.02.001","article-title":"The Pleural Mesothelium and Transforming Growth Factor-\u03921 Pathways in Restrictive Allograft Syndrome: A Pre-Clinical Investigation","volume":"38","author":"Sacreas","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1111\/ajt.16360","article-title":"Type-1 Immunity and Endogenous Immune Regulators Predominate in the Airway Transcriptome During Chronic Lung Allograft Dysfunction","volume":"21","author":"Iasella","year":"2021","journal-title":"Am J Transplant"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1111\/ajt.13281","article-title":"Impact of CLAD Phenotype on Survival After Lung Retransplantation: A Multicenter Study","volume":"15","author":"Verleden","year":"2015","journal-title":"Am J Transplant"},{"key":"B22","doi-asserted-by":"publisher","first-page":"3045","DOI":"10.1111\/ajt.15019","article-title":"Pirfenidone in Restrictive Allograft Syndrome After Lung Transplantation: A Case Series","volume":"18","author":"Vos","year":"2018","journal-title":"Am J Transplant"},{"key":"B23","doi-asserted-by":"publisher","first-page":"100626","DOI":"10.1016\/j.trre.2021.100626","article-title":"The Potential of Biomarkers of Fibrosis in Chronic Lung Allograft Dysfunction","volume":"35","author":"van der Ploeg","year":"2021","journal-title":"Transplant Rev"}],"container-title":["Transplant International"],"original-title":[],"link":[{"URL":"https:\/\/www.frontierspartnerships.org\/articles\/10.3389\/ti.2024.12395\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T15:07:20Z","timestamp":1706713640000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontierspartnerships.org\/articles\/10.3389\/ti.2024.12395\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,26]]},"references-count":23,"alternative-id":["10.3389\/ti.2024.12395"],"URL":"https:\/\/doi.org\/10.3389\/ti.2024.12395","relation":{},"ISSN":["1432-2277"],"issn-type":[{"value":"1432-2277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,26]]},"article-number":"12395"}}